- 专利标题: Tissue thickness compensator comprising controlled release and expansion
-
申请号: US13433141申请日: 2012-03-28
-
公开(公告)号: US10123798B2公开(公告)日: 2018-11-13
- 发明人: Chester O. Baxter, III , Frederick E. Shelton, IV , Charles J. Scheib , Christopher W. Widenhouse , William B. Weisenburgh, II , John L. Stammen , Mark H. Ransick , Stephanie A. Mutchler , Gary W. Knight , Michael S. Cropper , Sean P. Conlon , Jeffrey S. Swayze
- 申请人: Chester O. Baxter, III , Frederick E. Shelton, IV , Charles J. Scheib , Christopher W. Widenhouse , William B. Weisenburgh, II , John L. Stammen , Mark H. Ransick , Stephanie A. Mutchler , Gary W. Knight , Michael S. Cropper , Sean P. Conlon , Jeffrey S. Swayze
- 申请人地址: US PR Guaynabo
- 专利权人: Ethicon LLC
- 当前专利权人: Ethicon LLC
- 当前专利权人地址: US PR Guaynabo
- 主分类号: A61B17/072
- IPC分类号: A61B17/072 ; A61B17/00 ; A61B17/064 ; A61B17/115 ; A61B17/29 ; A61B17/32
摘要:
A tissue thickness compensator may generally comprise a first layer comprising a first biocompatible material sealingly enclosed in a water impermeable material and a second layer comprising a second biocompatible material comprising at least one encapsulation, wherein the first biocompatible material expands when contacted with a fluid. The tissue thickness compensator may comprise a haemostatic agent, an anti-inflammatory agent, an antibiotic agent, anti-microbial agent, an anti-adhesion agent, an anti-coagulant agent, a medicament, and/or pharmaceutically active agent. The encapsulation may comprise a biodegradable material to degrade in vivo and/or in situ. The tissue thickness compensator may comprise a hydrogel. The reaction product may comprise a fluid-swellable composition. Articles of manufacture comprising the tissue thickness compensator and methods of making and using the tissue thickness compensator are also described.
公开/授权文献
信息查询